Free Trial

Rapid Micro Biosystems (RPID) Stock Price, News & Analysis

Rapid Micro Biosystems logo
$3.58 +0.10 (+2.87%)
Closing price 06/27/2025 04:00 PM Eastern
Extended Trading
$3.56 -0.02 (-0.70%)
As of 06/27/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Rapid Micro Biosystems Stock (NASDAQ:RPID)

Key Stats

Today's Range
$3.41
$3.60
50-Day Range
$2.25
$3.76
52-Week Range
$0.58
$4.04
Volume
116,893 shs
Average Volume
196,260 shs
Market Capitalization
$156.91 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.00
Consensus Rating
Strong Buy

Company Overview

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides onsite technical training services. Its solutions are used in environmental monitoring, water, bioburden, and sterility release testing applications. In addition, the company offers RMBNucleus software for the Growth Direct system; RMBNucleus Mold Alarm signals at the first sign of mold detection; RMBNucleus Central Manager portal streamlines coordination of multiple instruments; and Growth Direct LIMS connection software. Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. The company was incorporated in 2006 and is headquartered in Lowell, Massachusetts.

Rapid Micro Biosystems Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
40th Percentile Overall Score

RPID MarketRank™: 

Rapid Micro Biosystems scored higher than 40% of companies evaluated by MarketBeat, and ranked 718th out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Earnings Growth

    Earnings for Rapid Micro Biosystems are expected to grow in the coming year, from ($1.10) to ($0.94) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Rapid Micro Biosystems is -3.48, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Rapid Micro Biosystems is -3.48, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Rapid Micro Biosystems has a P/B Ratio of 2.05. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Rapid Micro Biosystems' valuation and earnings.
  • Percentage of Shares Shorted

    3.47% of the float of Rapid Micro Biosystems has been sold short.
  • Short Interest Ratio / Days to Cover

    Rapid Micro Biosystems has a short interest ratio ("days to cover") of 5.1.
  • Change versus previous month

    Short interest in Rapid Micro Biosystems has recently decreased by 6.71%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Rapid Micro Biosystems does not currently pay a dividend.

  • Dividend Growth

    Rapid Micro Biosystems does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.47% of the float of Rapid Micro Biosystems has been sold short.
  • Short Interest Ratio / Days to Cover

    Rapid Micro Biosystems has a short interest ratio ("days to cover") of 5.1.
  • Change versus previous month

    Short interest in Rapid Micro Biosystems has recently decreased by 6.71%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Rapid Micro Biosystems has a news sentiment score of 1.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.93 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Rapid Micro Biosystems this week, compared to 1 article on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Rapid Micro Biosystems insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    29.96% of the stock of Rapid Micro Biosystems is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    52.60% of the stock of Rapid Micro Biosystems is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Rapid Micro Biosystems' insider trading history.
Receive RPID Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Rapid Micro Biosystems and its competitors with MarketBeat's FREE daily newsletter.

RPID Stock News Headlines

New Rule Hits in July — The Smart Money Already Moved
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
See More Headlines

RPID Stock Analysis - Frequently Asked Questions

Rapid Micro Biosystems' stock was trading at $0.90 on January 1st, 2025. Since then, RPID shares have increased by 297.8% and is now trading at $3.58.
View the best growth stocks for 2025 here
.

Rapid Micro Biosystems, Inc. (NASDAQ:RPID) issued its quarterly earnings data on Friday, May, 9th. The company reported ($0.26) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.27) by $0.01. The firm had revenue of $7.21 million for the quarter, compared to analyst estimates of $6.63 million. Rapid Micro Biosystems had a negative net margin of 151.22% and a negative trailing twelve-month return on equity of 56.07%.
Read the conference call transcript
.

Rapid Micro Biosystems (RPID) raised $125 million in an initial public offering (IPO) on Thursday, July 15th 2021. The company issued 6,600,000 shares at a price of $18.00-$20.00 per share.

Shares of RPID stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Rapid Micro Biosystems investors own include Avino Silver & Gold Mines (ASM), Advanced Micro Devices (AMD), Black Stone Minerals (BSM), Essex Property Trust (ESS), Iovance Biotherapeutics (IOVA), JPMorgan Chase & Co. (JPM) and 3M (MMM).

Company Calendar

Last Earnings
5/09/2025
Today
6/29/2025
Next Earnings (Estimated)
8/01/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Measuring And Control Equipment
Current Symbol
NASDAQ:RPID
Fax
N/A
Employees
200
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$8.00
High Stock Price Target
$8.00
Low Stock Price Target
$8.00
Potential Upside/Downside
+123.5%
Consensus Rating
Strong Buy
Rating Score (0-4)
4.00
Research Coverage
1 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$46.89 million
Net Margins
-151.22%
Pretax Margin
-151.13%

Debt

Sales & Book Value

Annual Sales
$28.05 million
Price / Cash Flow
N/A
Book Value
$1.75 per share
Price / Book
2.05

Miscellaneous

Free Float
30,700,000
Market Cap
$156.91 million
Optionable
Not Optionable
Beta
1.32
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NASDAQ:RPID) was last updated on 6/30/2025 by MarketBeat.com Staff
From Our Partners